Back to all AI Solutions
ProFound AI Breast Health Suite
ProFound AI precisely identifies subtle, early lesions and scores the case for an overall suspicion of cancer, while also reporting density and risk stratification.
Backed by clinical evidence, proven outcomes, and thousands of global users, ProFound AI delivers unmatched accuracy, multi-vendor compatibility, and workflow advantages, empowering earlier cancer detection and transforming lives.
ProFound Detection V4 is FDA Cleared. ProFound AI V3 and PowerLook Density Assessment are FDA Cleared, CE Marked, and Health Canada Licensed. ProFound AI Risk is CE Marked and Health Canada Licensed. Products may not be available in all geographies.
Key benefits
- 8.4% Improvement in sensitivity
- 7.2% Reduction in recall rate
- 52% Reduction in reading time
- 88.1% AUC Specificity/Sensitivity
Details
- Regulatory:
CE
FDA
MMG
Breast
Senology
Oncology
TGA
- Clinical Applications:
CE
FDA
MMG
Breast
Senology
Oncology
TGA
- Modality:
CE
FDA
MMG
Breast
Senology
Oncology
TGA
- Body Part:
CE
FDA
MMG
Breast
Senology
Oncology
TGA
Peer-reviewed publications
Improving Accuracy and Efficiency with Concurrent Use of Artificial Intelligence for Digital Breast Tomosynthesis Read
Discover the power of AI for your studies
Schedule a demo today
